Sage Search Advisors

Old Greenwich Consultants is a boutique executive search firm specializing in talent assessment and acquisition within the private wealth management industry, boasting over 25 years of experience. The firm partners with prestigious financial services companies across the United States to identify and place top-tier financial professionals in roles that align with their skills and aspirations. Dedicated to fostering strong relationships with both clients and candidates, Old Greenwich Consultants emphasizes professionalism, integrity, and discretion throughout the recruitment process. With a focus on personalized service, they successfully manage a diverse range of placements, from entry-level associates to seasoned executives, ensuring a perfect match for both parties. Generated from the website

Buchwald Capital Advisors LLC, a boutique investment bank specializing in financial restructuring advisory services, was founded in 2001 by Lee E. Buchwald. Mr. Buchwald is a twenty-five year veteran investment banker who has been an executive at such prominent firms as Rothschild Inc., Salomon Smith Barney and Chanin Capital Partners. Mr. Buchwald has been responsible for over 50 restructuring transactions. In addition to financial restructuring advisory services, Mr. Buchwald's transactions have included: mergers and acquisitions, private and public offerings of securities, valuations and fairness opinions. Please see the Experience section for a detailed review of Mr. Buchwald's professional experience and education. Ovation, Inc Restructuring and M&A Pameco Liquidating Trust Liquidating Trustee REASONS FOR SELECTING BUCHWALD CAPITAL ADVISORS LLC Professional Experience: Mr. Buchwald is a seasoned investment banker with a twenty-five year track record of successful transactions. Since he is the only executive at the firm, clients are guaranteed to get senior level attention at all times. Priority Service: As a small boutique investment bank, Buchwald Capital Advisors can only handle a few matters at a time. Consequently, every transaction receives the attention it deserves and no responsibilities are handed down to junior staff members. Competitive Fees: Due to its size, Buchwald Capital Advisors has greater flexibility in structuring fee arrangements than larger firms do. Likewise, the firm is able to charge fees that are significantly lower than its larger competitors while providing quality of services equal to or better than that which is available elsewhere.

New Leaf Venture Partners' objectives with each investment are to back a strong, entrepreneurial management team, to provide appropriate financial resources, to help build a great company, and to create exceptional equity value. We are active investors and almost always serve as directors of our portfolio companies, who can draw upon perspectives and experiences of the entire NLV investment team and its network of successful scientists, clinicians, operating executives and entrepreneurs. We assist in building management teams, guiding corporate strategy, providing input to operating plans, and in making decisions about optimal paths for future financings and exits. As conditions evolve, NLV Partners team continually refines its differentiated strategy in healthcare investing. Both of NLV's latest funds, New Leaf Ventures I and New Leaf Ventures II, focus on taking leadership positions in: Biopharmaceuticals - NLV has an in-depth understanding of therapeutic targets and modalities, the drug R&D process, clinical trial design, regulatory requirements, and pharmaceutical commercial activities. NLV's extensive medical, clinical development, commercial and financial experience helps companies navigate the challenging path to regulatory approval and commercialization as stand-alone companies or through value-added strategic partnerships. NLV invests in companies at all stages in this sector, but looks at the level of risk, costs, and timelines to build real value in the underlying program (s) in determining if an investment fits our strategy. NLV has been particularly active in starting and investing in companies that been formed around the spin out of programs from larger pharmaceutical and biotech companies. Medical devices - NLV works closely with its network of entrepreneurs and scientific and medical founders to identify investment opportunities around promising technologies targeting areas of high unmet medical need and large commercial potential. The current strategy is to focus on later stage opportunities to provide growth capital or the last round to profitability in which regulatory and reimbursement risks are minimal. NLV will invest in early stage companies when there are large established global markets and an opportunity to prove safety and effectiveness in a focused, cost effective program. NLV's investment team brings critical operating experience and the ability to evaluate the biological, engineering, regulatory, reimbursement and market risks most relevant to starting, growing, developing and exiting young or more mature companies in the medical devices sector.